What Is 2-amino-2-deoxyisochorismate synthase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-amino-2-deoxyisochorismate synthase is an enzyme involved in the biosynthesis of siderophores, specifically in the salicylate pathway of Mycobacterium tuberculosis, with activity first characterized in 2007. It catalyzes the conversion of chorismate to 2-amino-2-deoxyisochorismate using L-glutamine as an amino donor.

Key Facts

The enzyme was first identified in Mycobacterium tuberculosis in 2007.
It plays a critical role in the biosynthesis of mycobactin, a siderophore essential for iron uptake.
The reaction occurs in the cytoplasm under iron-limited conditions.
It belongs to the aminotransferase enzyme family with EC number 2.6.1.-.
Knockout studies show >90% reduction in siderophore production when the gene is inactivated.

Overview

2-amino-2-deoxyisochorismate synthase is a specialized bacterial enzyme involved in the early stages of siderophore biosynthesis, particularly in pathogenic strains like Mycobacterium tuberculosis. This enzyme plays a pivotal role in enabling bacteria to scavenge iron from their host environment, a critical survival mechanism during infection.

Found primarily in actinobacteria, the enzyme catalyzes a key transformation in the salicylate-dependent pathway, converting chorismate into 2-amino-2-deoxyisochorismate. This reaction is essential for the downstream production of mycobactin, a siderophore that enhances bacterial virulence and persistence in low-iron environments.

Gene designation: The enzyme is encoded by the mbtI gene in Mycobacterium tuberculosis, identified through genomic analysis in 2007.
Substrate specificity: It uses chorismate and L-glutamine as primary substrates, with chorismate being a central metabolite in aromatic amino acid pathways.
Reaction product: The enzyme produces 2-amino-2-deoxyisochorismate, a precursor for salicylate, which is then incorporated into mycobactin.
Cellular location: The enzyme functions in the cytoplasm, where iron-dependent regulation controls its expression levels.
Enzyme class: It is categorized under aminotransferases, though its exact EC number remains under review due to unique substrate handling.

How It Works

The enzymatic mechanism of 2-amino-2-deoxyisochorismate synthase involves a two-step transformation that integrates nitrogen from glutamine into the chorismate backbone. This process is tightly regulated by iron availability, ensuring production only when needed.

Chorismate binding: Chorismate binds to the active site with Km = 45 μM, indicating moderate substrate affinity under physiological conditions.
Glutamine hydrolysis: The enzyme hydrolyzes L-glutamine to release ammonia, which is then channeled internally for the amination step.
Amination reaction: Ammonia attacks chorismate at the C2 position, forming the amino-substituted intermediate 2-amino-2-deoxyisochorismate.
Iron regulation: Expression is repressed by iron via the IdeR protein, with up to 15-fold induction under iron starvation.
Cofactor independence: Unlike many aminotransferases, this enzyme does not require pyridoxal phosphate, relying instead on direct ammonia transfer.
Enzyme kinetics: The kcat value is 0.8 min⁻¹, reflecting a relatively slow but specific catalytic rate optimized for metabolic flux control.

Comparison at a Glance

Below is a comparison of 2-amino-2-deoxyisochorismate synthase with related enzymes in siderophore biosynthesis across bacterial species.

Organism	Enzyme Name	Gene	Substrate	Product
Mycobacterium tuberculosis	2-amino-2-deoxyisochorismate synthase	mbtI	Chorismate + glutamine	2-amino-2-deoxyisochorismate
Escherichia coli	2,3-dihydro-2,3-dihydroxybenzoate synthase	entC	Chorismate	2,3-DHB
Pseudomonas aeruginosa	Salicylate synthase	pchA	Chorismate	Salicylate
Bacillus subtilis	YbbA homolog	ybbA	Chorismate	Unknown intermediate
Yersinia enterocolitica	YbtA-regulated synthase	irp9	Chorismate	Yersiniabactin precursor

While all these enzymes use chorismate as a starting point, 2-amino-2-deoxyisochorismate synthase is unique in its use of glutamine for amination and its role in mycobactin synthesis. This makes it a target for anti-tuberculosis drug development, as disrupting iron acquisition weakens bacterial survival in human hosts.

Why It Matters

Understanding this enzyme's function opens doors to novel antimicrobial strategies, especially for drug-resistant tuberculosis. Its absence in humans makes it an ideal therapeutic target with minimal off-target effects.

Drug development: Inhibitors targeting mbtI could disrupt iron uptake, reducing bacterial load in chronic infections.
Diagnostic potential: Detection of mycobactin precursors may serve as a biomarker for active TB infection.
Antibiotic specificity: The pathway is absent in humans, minimizing toxicity risks in drug design.
Resistance mitigation: Targeting virulence rather than growth may reduce selective pressure for resistance.
Metabolic engineering: Modified versions could be used in synthetic biology for novel siderophore production.
Evolutionary insight: Conservation across mycobacteria suggests an ancient, optimized iron acquisition mechanism.

As research progresses, 2-amino-2-deoxyisochorismate synthase continues to emerge as a linchpin in microbial iron metabolism, bridging biochemistry and infectious disease control. Its study exemplifies how understanding enzyme function can lead to tangible medical advances.